FULC

Fulcrum Therapeutics, Inc. Common Stock
Data: 2026-02-02
$10.72
Price
-0.70%
Change
$15.7399
52W High
$2.315
52W Low

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

Quick Stats
Feb 02, 2026

54.8

AI Score

HOLD

0.67

Volume Ratio

Feb 24, 2026

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

FULC Stock Summary

Last updated Feb 02, 2026

FULC is currently trading at $10.72, positioned above its 200-day moving average of $8.19, indicating a long-term uptrend. The stock has a 52-week range of $2.315 to $15.7399.

Technical Analysis: The 50-day moving average stands at $11.17, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 49.209, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.065, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates FULC at 54.8/100 with a HOLD recommendation.

FULC (Fulcrum Therapeutics, Inc. Common Stock) Indicators

Last updated Feb 02, 2026

Indicator Value
RSI(14) 49.209
CMF (20) -0.065
ROC (10) 5.72
ADX (14) 11.1
Indicator Value
MACD (12,26,9) -0.048
AROONOSC (14) 57.143
WILLAMS %R (14) -30.306
MFI (14) 78.485
FULC Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

FULC Price vs Max Options Open Interest
FULC Max Change In Options Open Interest

FULC Options - Sort by Max open Interest (near term)

3rd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

FULC Daily Out of Money Options - Sort by Max open Interest (near term)

3rd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

FULC Daily In the Money Options - Sort by Max open Interest (near term)

3rd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

FULC Most Active Options by Volume(near term)

3rd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Fulcrum Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

FULC Moving Averages Analysis

Fulcrum Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026

FULC (Fulcrum Therapeutics, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Feb 02, 2026

Days MA
10 10.75
20 10.44
30 10.91
50 11.17
100 9.89
200 8.19

FULC Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 707.9 million
Earnings/Share ($) -1.14
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -1.1716
EPS Estimate Next Year ($) -1.2187
WallStreet Target Price ($) 19.1
Most Recent Quarter